2009
DOI: 10.1016/j.neures.2009.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Analgesic effect of milnacipran is associated with c-Fos expression in the anterior cingulate cortex in the rat neuropathic pain model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
21
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 28 publications
2
21
0
Order By: Relevance
“…These differences may underlie brain region and cell type-specific effects of stress and nerve injury on Cyr61 and Dusp1 expression, or may suggest that these genes play distinct roles in neuropathic pain versus chronic stress states. Moreover, we observed decreases in Fos expression in the NAc of SNI and CUS mice, and although the antidepressants imipramine (104), and milnacipran (10) enhance c-Fos expression in the PFC of rats, homozygous Fos KO mice show reduced anxiety-like behaviors (105). Nevertheless, these observations highlight the value of network-wide analysis, and the potential detrimental effects disruptions in normal gene expression (be it enhanced or decreased) may exert on normal emotional function.…”
Section: Discussionmentioning
confidence: 82%
See 1 more Smart Citation
“…These differences may underlie brain region and cell type-specific effects of stress and nerve injury on Cyr61 and Dusp1 expression, or may suggest that these genes play distinct roles in neuropathic pain versus chronic stress states. Moreover, we observed decreases in Fos expression in the NAc of SNI and CUS mice, and although the antidepressants imipramine (104), and milnacipran (10) enhance c-Fos expression in the PFC of rats, homozygous Fos KO mice show reduced anxiety-like behaviors (105). Nevertheless, these observations highlight the value of network-wide analysis, and the potential detrimental effects disruptions in normal gene expression (be it enhanced or decreased) may exert on normal emotional function.…”
Section: Discussionmentioning
confidence: 82%
“…Top, mPFC: Capn11 (t (16) = −2.83, p = 0.012), Capn2 (t (10) = −0.02, p = 0.669), Capn1 (t (10) = 1.44, p = 0.168), Btg2 (t (10) = 2.35, p = 0.041), Cyr61 (t (10) = 2.48, p = 0.033), Tph2 (t (10) = 2.61, p = 0.037), Dusp1 (t (14) = 4.27, p < 0.001), F2rl1 (t (10) = −1.28, p = 0.23. Middle, NAc: Capn11 (t (10) = −3.06, p = 0.012), Capn2 (t (10) = 0.61, p = 0.558), Capn1 (t (10) = −0.15, p = 0.883), Btg2 (t (10) = 4.14, p = 0.002), Ccl3 (t (10) = −2.26, p = 0.048), Cyp2e1 (t (12) = 2.54, p = 0.026), Fos (t (10) = 4.57, p = 0.001), Oacyl (t (10) = 3.27, p = 008). Bottom, PAG: Capn11 (t (12) = −4.15, p < 0.001), Capn2( t (10) = −0.91, p = 0.383), Capn1 (t (10) = −0.36, p = 0.727), Mt1 (t (10) = −6.14, p < 0.001), Slc17a8 (t (10) = 3.12, p = 0.011), Sgk1 (t (10) = −3.03, p = 0.013), Vgf (t (14) = − 4.15, p < 0.001), Pde6g (t (10) = −0.92, p= 0.380).…”
Section: Figmentioning
confidence: 99%
“…These changes occur through both presynaptic glutamate and postsynaptic AMPA alterations, mediated by adenyl cyclase [104]. Increased expression of the c-Fos gene (a marker for noxious stimuli activated neurons) has been correlated with persistent pain, which is blocked by SNRI medications [105]. Persistent pain models also demonstrate a decrease in ACC cannabinoid 1 receptor sensitivity rather than a decrease in number of receptors [106].…”
Section: Cingulate Cortexmentioning
confidence: 99%
“…Normalisation of ACC hyperperfusion following treatment could be explained by activation of the endogenous opioid system. In terms of duloxetine-specific factors, in ACC, the expression of c-Fos, a useful parameter of pain,37 38 was found to be inhibited by administering serotonin-norepinephrine reuptake inhibitor (SNRI) milnacipran 39. SNRI administration was also associated with a reduction in pain scores and decrease in the functional connectivity between the rostral ACC and insula in patients with fibromyalgia 40.…”
Section: Discussionmentioning
confidence: 99%